Publications by authors named "Barbara Cosci"

Claim this Profile
E
Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series.
Raffaele Ciampi, Caterina Mian, Laura Fugazzola, Barbara Cosci, Cristina Romei

Thyroid· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low prevalence of the somatic M918T RET mutation in micro-medullary thyroid cancer.
Cristina Romei, Clara Ugolini, Barbara Cosci, Liborio Torregrossa, Agnese Vivaldi

Thyroid· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.
Rossella Elisei, Cristina Romei, Giulia Renzini, Valeria Bottici, Barbara Cosci

J Clin Endocrinol Metab· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma.
Raffaele Ciampi, Cristina Romei, Barbara Cosci, Agnese Vivaldi, Valeria Bottici

Mol Cell Endocrinol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes.
Cristina Romei, Stefano Mariotti, Laura Fugazzola, Augusto Taccaliti, Furio Pacini, Barbara Cosci

Eur J Endocrinol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors.
Raffaele Ciampi, Agnese Vivaldi, Cristina Romei, Alberto Del Guerra, Piero Salvadori, Barbara Cosci

Mol Cell Endocrinol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.
Rossella Elisei, Barbara Cosci, Cristina Romei, Valeria Bottici, Giulia Renzini

J Clin Endocrinol Metab· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
Rossella Elisei, Cristina Romei, Barbara Cosci, Laura Agate, Valeria Bottici

J Clin Endocrinol Metab· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition.
Rossella Elisei, Barbara Cosci, Cristina Romei, Laura Agate, Pamela Piampiani

J Clin Endocrinol Metab· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior.
Rosa Paula Biscolla, Clara Ugolini, Mariangela Sculli, Valeria Bottici, Maria Grazia Castagna, Barbara Cosci

Thyroid· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population.
Rossella Elisei, Barbara Cosci, Cristina Romei, Valeria Bottici, Mariangela Sculli

J Clin Endocrinol Metab· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis